Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2003
11/20/2003CA2480378A1 Novel azacyclic ethynyl derivatives
11/20/2003CA2451081A1 Adenosine a<sb>3</sb> receptor modulators
11/19/2003EP1362916A2 Human tumor necrosis factor delta and epsilon
11/19/2003EP1362911A1 Transgenic animal having drug metabolism enzyme gene and utilization thereof
11/19/2003EP1362869A1 Resistant starch prepared by isoamlase debranching of low amylose starch
11/19/2003EP1362858A1 Pyrrolopyrimidinone derivates, process of preparation and use
11/19/2003EP1362848A1 Process for the preparation of vitamin D derivatives
11/19/2003EP1362602A1 Coated medical devices for the treatment of vascular disease
11/19/2003EP1362601A1 Method of examining effect of angionegesis inhibitor mediated by the inhibition of integrin expression
11/19/2003EP1362598A1 Active oxygen generator containing photosensitizer for ultrasonic therapy
11/19/2003EP1362592A1 Use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-kB
11/19/2003EP1362590A1 Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
11/19/2003EP1362097A2 Champ-a cardiac helicase-like factor
11/19/2003EP1362095A2 Post-partum mammalian placenta, its use and placental stem cells therefrom
11/19/2003EP1362061A2 Antibodies that bind both bcma and taci
11/19/2003EP1362054A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
11/19/2003EP1362052A1 Inhibitors of cruzipain and other cysteine proteases
11/19/2003EP1362050A1 Pyrimidine derivatives for inhibition of cell-proliferation
11/19/2003EP1362048A1 Triazolo compounds as mmp inhibitors
11/19/2003EP1362047A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors
11/19/2003EP1362046A1 Substituted pyrimidinone derivatives as ligands of integrin receptors
11/19/2003EP1362045A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/19/2003EP1362044A1 Phthalazinone-piperidino-derivatives as pde4 inhibitors
11/19/2003EP1362043A1 Lactone compounds as novel photoinitiators
11/19/2003EP1362041A1 Aryl carbamate derivatives, preparation and use thereof
11/19/2003EP1362033A1 Pyridine matrix metalloproteinase inhibitors
11/19/2003EP1362031A1 Pharmaceutically active piperidine derivatives
11/19/2003EP1362030A1 Novel benzoylguanidine salt
11/19/2003EP1362028A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP1361896A2 Localized myocardial injection method for treating ischemic myocardium
11/19/2003EP1361887A2 Angiogenically effective unit dose of fgf-2 and method of use
11/19/2003EP1361882A1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
11/19/2003EP1361880A2 6-substituted pyrido-pyrimidines
11/19/2003EP1361874A1 Treatment of diseases characterized by excessive or insufficient cell death
11/19/2003EP1361873A2 Matrix metalloproteinase inhibitors
11/19/2003EP1361870A2 A substance for use in a dietary supplement or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
11/19/2003EP1361868A1 Novel modified release formulation
11/19/2003EP1361864A2 Mucoadhesive pharmaceutical formulations
11/19/2003EP1179005B1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/19/2003EP1121107B1 Sertraline oral concentrate
11/19/2003EP1117628B1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
11/19/2003EP1086124B1 Novel cyclosporins
11/19/2003EP1017667B1 2-Amino-6-methyl-7-acetyl-tetraline and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
11/19/2003EP1003738B1 Bicyclic compounds as ligands for 5-ht1 receptors
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0852226B1 Pyrimidine derivatives
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/19/2003CN1457261A Method and compositions for prevention or treatment of cancer
11/19/2003CN1457257A Extended native chemical ligation
11/19/2003CN1456664A Reorganized human glycogen phosphorylase isoenzyme BB and preparation thereof by methanal yeast and use thereof
11/19/2003CN1456660A Ginkgo juice extracting method, food and medicine therefrom
11/19/2003CN1456568A Organic salts of parabuxinidine-D, their preparations and uses
11/19/2003CN1456352A Medicinal composition containing fiber eliminating enzyme
11/19/2003CN1456336A Rhodiola root powdery injection and its preparation
11/19/2003CN1456333A Capsules against thrombus and preparation thereof
11/19/2003CN1456322A Fast-effective haemorrhoids cream
11/19/2003CN1456318A Xinnaolitong capsules for cardio-cerebral diseases
11/19/2003CN1456309A Antilipemic antiatherosclerosis medicine composition and preparing method, application thereof
11/19/2003CN1456306A Cattail pollen total extractive, preparation and preparing method thereof
11/19/2003CN1456285A Preparation of snake gallbladder and tangerine peel dispersed tablets
11/19/2003CN1456279A Chinese medicine decoction for treating acne
11/19/2003CN1456191A Chinese medicine powder for curing cardiovascular disease and preparing method thereof
11/19/2003CN1456188A Use of red rage root and notoginseng in preparation of medicine for prevention of cerebral apoplexy
11/19/2003CN1456187A Use of red sage root and notoginseng in preparation of medicine for prevention of acute coronary syndrome
11/19/2003CN1456183A Toilet paper against anal fissure and piles
11/19/2003CN1456179A Chinese medicine preparation for curing angitis
11/19/2003CN1456169A Preparation with haw leaf extractive as main effect composition
11/19/2003CN1456165A Method for increasing solubility of parabuxinidine-D injection
11/19/2003CN1456164A Parabuxinidine pills and preparation thereof
11/19/2003CN1456153A Preparing method for Xiatianwu alkaloids
11/19/2003CN1456150A Garlicin injection preparation
11/19/2003CN1128147C 3-oxo-2(H)-1,2,4-triazine deriatives as ligands of 5HT1A receptors
11/19/2003CN1128144C Indane-1-alcohol compound, its preparation method and medical composition containing same
11/19/2003CN1128142C Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
11/19/2003CN1127967C Capsules for hypertension and their preparation
11/18/2003US6649648 Administering 1-chroman, 1-thiochroman or quinoline derivative as anticarcinogenic or antimetastasis agent
11/18/2003US6649642 Succinate derivative compounds useful as cysteine protease inhibitors
11/18/2003US6649641 Glucagon antagonists/inverse agonists
11/18/2003US6649640 Isoxazole compositions useful as inhibitors of ERK
11/18/2003US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/18/2003US6649622 Treating diabetes, especially Type II diabetes
11/18/2003US6649619 Compounds
11/18/2003US6649618 Substituted amidoalkyl-uracils and their use
11/18/2003US6649617 Treatment for stroke management
11/18/2003US6649616 For therapy and prophylaxis of cardiovascular disorders caused by ischaemia
11/18/2003US6649613 Diacylhydrazine derivatives
11/18/2003US6649612 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them
11/18/2003US6649611 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
11/18/2003US6649608 Cyclin-dependent serine/threonine and focal adhesion kinase inhibitors
11/18/2003US6649607 Compositions and methods for treating or preventing convulsions or seizures
11/18/2003US6649604 Analgesics; antidiabetic agents; antiinflamamtory agents
11/18/2003US6649600 2,6-Dioxo or dithioxy-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo derivatives; highly potent and selective diuretics
11/18/2003US6649591 Dithiocarbamates linked to the surface of a non-immunogenic, non-targeting macromolecule other than an antibody (e.g., albumin protein); treating cerebral stroke and other ischemia/reperfusion injury
11/18/2003US6649421 Antigen binding protein; use in diagnosis and treatment of cardiac infarction, stroke, arterial occlusion disease and kidney failure due to endothelial dysfunction
11/18/2003US6649388 Polypeptides derived from JNK3
11/18/2003US6649168 Pharmaceutical compositions comprising TGF-beta
11/18/2003CA2264155C N6 heterocyclic substituted adenosine derivatives
1 ... 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 ... 1595